Current demand for plastics and chemical raw materials is met through large-scale production of ethylene from fossil fuels.

As the use of AI spreads through every industry and becomes more of a part of our lives every day, researchers are also ...

With heightened sustainability expectations, facility managers face a challenge: separating genuine eco-innovation from ...

A groundbreaking FDA approval offers the first-ever treatment for ultra-rare Thymidine Kinase 2 Deficiency (TK2d). KYGEVVI, a ...

Not only do the makers of Kinmemai Premium claim that it’s the world’s best rice, but in 2016 Guinness World Records ...

New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role ...

New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role against oxidative stress in neurons, independent of its role producing the ...

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

Chiesi Global Rare Diseases, a business unit of the Chiesi Group, and Protalix BioTherapeutics, Inc. (NYSE American: PLX), have requested a re-examination of the recent negative opinion issued by the ...

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today ...

A two-in-one step to remove pore-clogging dirt, oil, and dead skin cells to reveal a brighter, smoother complexion.